Surgical Resection Outcomes in Patients With Brain Metastasis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-01

Study Completion Date

2024-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

While many studies have investigated the prognostic factors for patients undergoing surgical resection for primary brain tumors, decision-making for patients with brain metastasis (BM) is more complex because of their higher burden of comorbidities compared to those with primary brain tumors. In addition, although various prognostic indicators have been identified to predict prognosis in several types of cancer, such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), prognostic nutritional index (PNI), and systemic immune-inflammation index (SII), limited studies have yet determined which group of patients would yield beater survival outcome after surgical resection for BM. This study aimed to investigate the impact of patient and perioperative characteristics and prognostic indicators on survival outcome of patients undergoing surgical resection of BM.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Treatments for Brain Metastases With Poor Prognostic Factors

NCT05609162

Brain Metastases

UNKNOWN

ioMRI in the Surgery of Brain Metastases.

NCT07197632

Brain Metastases

RECRUITING NA

Postoperative Complications Following Skull Base Tumor Resection

NCT06587906

Skull Base Tumor Postoperative Complications

RECRUITING

Preop fSRS for Resectable Brain Metastases

NCT05267587

Brain Metastases Brain Lesion

ACTIVE_NOT_RECRUITING PHASE2

Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor

NCT06929819

Glioblastoma Brain Tumor, Primary Brain Tumor - Metastatic

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Metastases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. patients with Clinical diagnosis of brain metastasis
2. patients who underwent craniotomy surgery for brain metastasis

Exclusion Criteria

1. patients with insufficient data for associated factors
2. patients who underwent stereotactic biopsy for brain metastasis
3. patients who did not undergo craniotomy surgery for brain metastasis

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No